Results 61 to 70 of about 31,178 (269)
Development of novel adenoviral vectors to overcome challenges observed with HAdV-5 based constructs [PDF]
Recombinant vectors based on human adenovirus serotype 5 (HAdV-5) have been extensively studied in pre-clinical models and clinical trials over the last two decades.
Julio Alonso-Padilla +215 more
core +4 more sources
Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment
Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan +8 more
wiley +1 more source
Strategies in Gene Therapy for Glioblastoma [PDF]
Glioblastoma (GBM) is the most aggressive form of brain cancer, with a dismal prognosis and extremely low percentage of survivors. Novel therapies are in dire need to improve the clinical management of these tumors and extend patient survival.
Behera, Prajna +4 more
core +2 more sources
Optimization of CEST MRI Reporter Protein Design Using Cation‐Pi Networks
A novel engineering approach can produce reporter proteins for cell and viral therapy tracking with unique magnetic resonance imaging (MRI) signatures, detectable with chemical exchange saturation transfer (CEST). We discover how cation‐π interactions between amino acid groups can help us fine‐tune magnetic resonance properties for noninvasive ...
David E. Korenchan +8 more
wiley +1 more source
Viral hijacking of cellular metabolism. [PDF]
This review discusses the current state of the viral metabolism field and gaps in knowledge that will be important for future studies to investigate.
Ch'ng, James +2 more
core
Micromanaging oncolytic viruses [PDF]
Two research teams have applied a microRNA-based strategy for restricting the replication of oncolytic viruses to their target tumors. The approach seeks to avoid attenuation of the viral genome, a currently used technique that has so far avoided off-target effects but also limited the effectiveness of these agents as cancer therapies.
openaire +1 more source
The combination therapy of oncolytic virotherapy
Introduction: Compared to other cancer immunotherapies, oncolytic viruses possess several advantages, including high killing efficiency, excellent targeting capabilities, minimal adverse reactions, and multiple pathways for tumor destruction.
Yue Wang +6 more
doaj +1 more source
Syncytia Formation in Oncolytic Virotherapy
Oncolytic virotherapy uses replication-competent virus as a means of treating cancer. Whereas this field has shown great promise as a viable treatment method, the limited spread of these viruses throughout the tumor microenvironment remains a major ...
Chase Burton, Eric Bartee
doaj +1 more source
Principles and Practice Guidelines of Microbiota Medicine: Statements From the CHINAGUT Conference
The 2025 CHINAGUT Conference convened a panel of 48 clinicians from 39 hospitals in 5 countries to develop 15 key statements, aimed at providing clinicians, educators, and healthcare administrators with a comprehensive framework to advance education, clinical practice, research, and public popularization in microbiota medicine.
Faming Zhang +52 more
wiley +1 more source
Fighting cancer with oncolytic viruses [PDF]
Although gene therapy has huge potential for modern medicine, our enthusiasm for its powerful potential must not cloud our judgment about the dangers of using increasingly diverse, yet relatively untested, replicating ...
Yuti, Chernajovsky +2 more
openaire +2 more sources

